1 / 7

Oligonucleotide Therapy Market Scope, Industry Key Drivers And Segmentation 2032

Global Oligonucleotide Therapy Market size is expected at $2.1 Bn by 2027 at a growth rate of 14.2%.

Download Presentation

Oligonucleotide Therapy Market Scope, Industry Key Drivers And Segmentation 2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Oligonucleotide Therapy Market Report 2023 Market Size, Trends and Global Forecast 2023-2032 © The Business Research Company. All Rights Reserved.

  2. Oligonucleotide Therapy Market Segments The Business Research Company segments it’s Oligonucleotide Therapy market report as: Antisense Oligonucleotide, Aptamer, Other Types By Type Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User By Application By End User Hospitals, Research Institutes © The Business Research Company. All Rights Reserved.

  3. Oligonucleotide Therapy Market Statistics The global oligonucleotide therapy market size grew from $1.1 billion in 2022 to $1.23 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%.The market size of global oligonucleotide therapy is expected to grow from $2.1 billion in 2027 at a CAGR of 14.2%. Global Oligonucleotide Therapy Market Size Forecast To 2032 2.1 1.23 1.1 2022 2023 2027 Click Here To Get A Sample Report © The Business Research Company. All Rights Reserved.

  4. Key Market Players Major players in the Oligonucleotide Therapy market are: ▪ Alnylam Pharmaceuticals Inc. ▪ Biogen Inc. ▪ Dynavax Technologies Corp. ▪ Ionis Pharmaceuticals Inc. ▪ And more. Get More Information On The Oligonucleotide Therapy Market Report © The Business Research Company. All Rights Reserved.

  5. 5 Reasons Why TBRC Is The Solution You Need 1. Measure the impact of high global inflation on market growth 2. Outperform competitors using forecast data and the drivers and trends shaping the market 3. Get a comprehensive market sizing report with a truly global perspective covering 60+ geographies from The Business Research Company, with data from 2017 to 2023 and forecasts up to 2032. 4. Assess the Russia-Ukraine war’s impact on commodity supply and its direct and indirect impact on all the markets 5. Benchmark performance against key competitors. © The Business Research Company. All Rights Reserved.

  6. Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. ✆ ✆ +44 207 1930 708 Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 info@tbrc.info ✆ ✆ +91 8897263534 @The Business Research Company. All rights reserved. © The Business Research Company. All Rights Reserved.

  7. Your Growth Insights Partner © The Business Research Company. All Rights Reserved.

More Related